156 related articles for article (PubMed ID: 19150344)
1. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance.
Zhou Y; Hopper-Borge E; Shen T; Huang XC; Shi Z; Kuang YH; Furukawa T; Akiyama S; Peng XX; Ashby CR; Chen X; Kruh GD; Chen ZS
Biochem Pharmacol; 2009 Mar; 77(6):993-1001. PubMed ID: 19150344
[TBL] [Abstract][Full Text] [Related]
2. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel.
Hopper-Borge E; Chen ZS; Shchaveleva I; Belinsky MG; Kruh GD
Cancer Res; 2004 Jul; 64(14):4927-30. PubMed ID: 15256465
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
5. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
[TBL] [Abstract][Full Text] [Related]
6. Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10).
Deng W; Dai CL; Chen JJ; Kathawala RJ; Sun YL; Chen HF; Fu LW; Chen ZS
Oncol Rep; 2013 Jun; 29(6):2479-85. PubMed ID: 23525656
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance.
Kuang YH; Shen T; Chen X; Sodani K; Hopper-Borge E; Tiwari AK; Lee JW; Fu LW; Chen ZS
Biochem Pharmacol; 2010 Jan; 79(2):154-61. PubMed ID: 19720054
[TBL] [Abstract][Full Text] [Related]
8. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).
Shen T; Kuang YH; Ashby CR; Lei Y; Chen A; Zhou Y; Chen X; Tiwari AK; Hopper-Borge E; Ouyang J; Chen ZS
PLoS One; 2009 Oct; 4(10):e7520. PubMed ID: 19841739
[TBL] [Abstract][Full Text] [Related]
9. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).
Chen JJ; Patel A; Sodani K; Xiao ZJ; Tiwari AK; Zhang DM; Li YJ; Yang DH; Ye WC; Chen SD; Chen ZS
PLoS One; 2013; 8(9):e74573. PubMed ID: 24069321
[TBL] [Abstract][Full Text] [Related]
10. Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.
Sun YL; Chen JJ; Kumar P; Chen K; Sodani K; Patel A; Chen YL; Chen SD; Jiang WQ; Chen ZS
PLoS One; 2013; 8(2):e55576. PubMed ID: 23393594
[TBL] [Abstract][Full Text] [Related]
11. The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond.
Chen DQ; Xie Y; Cao LQ; Fleishman JS; Chen Y; Wu T; Yang DH
Drug Resist Updat; 2024 Mar; 73():101062. PubMed ID: 38330827
[TBL] [Abstract][Full Text] [Related]
12. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump.
Teijaro CN; Munagala S; Zhao S; Sirasani G; Kokkonda P; Malofeeva EV; Hopper-Borge E; Andrade RB
J Med Chem; 2014 Dec; 57(24):10383-90. PubMed ID: 25419978
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).
Malofeeva EV; Domanitskaya N; Gudima M; Hopper-Borge EA
Cancer Res; 2012 Dec; 72(24):6457-67. PubMed ID: 23087055
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression.
Cheng J; Dai JY; Chen BA; Cai XH; Wang S; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):558-63. PubMed ID: 22739155
[TBL] [Abstract][Full Text] [Related]
16. [Reversal of multidrug resistance in drug-resistant cell line EAC/ADR by cepharanthine hydrochloride and its mechanism].
Song YC; Xia W; Jiang JH; Wang QD
Yao Xue Xue Bao; 2005 Mar; 40(3):204-7. PubMed ID: 15952589
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).
Chen ZS; Hopper-Borge E; Belinsky MG; Shchaveleva I; Kotova E; Kruh GD
Mol Pharmacol; 2003 Feb; 63(2):351-8. PubMed ID: 12527806
[TBL] [Abstract][Full Text] [Related]
18. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
Shiraishi N; Akiyama S; Nakagawa M; Kobayashi M; Kuwano M
Cancer Res; 1987 May; 47(9):2413-6. PubMed ID: 3567927
[TBL] [Abstract][Full Text] [Related]
19. β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter.
Guo HQ; Zhang GN; Wang YJ; Zhang YK; Sodani K; Talele TT; Ashby CR; Chen ZS
Oncol Rep; 2014 Feb; 31(2):858-66. PubMed ID: 24284783
[TBL] [Abstract][Full Text] [Related]
20. Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.
Hopper-Borge E; Xu X; Shen T; Shi Z; Chen ZS; Kruh GD
Cancer Res; 2009 Jan; 69(1):178-84. PubMed ID: 19118001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
